X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs MERCK LTD - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA MERCK LTD FULFORD INDIA/
MERCK LTD
 
P/E (TTM) x 398.8 33.2 1,202.2% View Chart
P/BV x 6.2 3.7 167.4% View Chart
Dividend Yield % 0.1 0.8 11.1%  

Financials

 FULFORD INDIA   MERCK LTD
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
MERCK LTD
Dec-16
FULFORD INDIA/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs9421,060 88.9%   
Low Rs450623 72.2%   
Sales per share (Unadj.) Rs691.4632.4 109.3%  
Earnings per share (Unadj.) Rs11.545.7 25.1%  
Cash flow per share (Unadj.) Rs15.462.3 24.6%  
Dividends per share (Unadj.) Rs2.0011.00 18.2%  
Dividend yield (eoy) %0.31.3 22.0%  
Book value per share (Unadj.) Rs380.0388.8 97.7%  
Shares outstanding (eoy) m3.9016.60 23.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 75.7%   
Avg P/E ratio x60.718.4 329.9%  
P/CF ratio (eoy) x45.313.5 335.6%  
Price / Book Value ratio x1.82.2 84.6%  
Dividend payout %17.424.1 72.5%   
Avg Mkt Cap Rs m2,71413,969 19.4%   
No. of employees `0000.41.6 28.0%   
Total wages/salary Rs m5051,487 34.0%   
Avg. sales/employee Rs Th6,073.06,631.9 91.6%   
Avg. wages/employee Rs Th1,137.4939.2 121.1%   
Avg. net profit/employee Rs Th100.7479.4 21.0%   
INCOME DATA
Net Sales Rs m2,69610,498 25.7%  
Other income Rs m125242 51.7%   
Total revenues Rs m2,82210,741 26.3%   
Gross profit Rs m-461,135 -4.1%  
Depreciation Rs m15276 5.5%   
Interest Rs m100-   
Profit before tax Rs m541,102 4.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10343 2.8%   
Profit after tax Rs m45759 5.9%  
Gross profit margin %-1.710.8 -15.9%  
Effective tax rate %17.731.1 56.8%   
Net profit margin %1.77.2 22.9%  
BALANCE SHEET DATA
Current assets Rs m1,7386,410 27.1%   
Current liabilities Rs m5458,828 6.2%   
Net working cap to sales %44.3-23.0 -192.1%  
Current ratio x3.20.7 439.6%  
Inventory Days Days4858 84.0%  
Debtors Days Days438 11.2%  
Net fixed assets Rs m121,406 0.8%   
Share capital Rs m39166 23.5%   
"Free" reserves Rs m1,4436,286 23.0%   
Net worth Rs m1,4826,455 23.0%   
Long term debt Rs m00-   
Total assets Rs m2,0778,828 23.5%  
Interest coverage x6.7NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.31.2 109.2%   
Return on assets %2.68.6 30.4%  
Return on equity %3.011.8 25.7%  
Return on capital %4.317.1 25.2%  
Exports to sales %08.3 0.0%   
Imports to sales %24.521.0 116.2%   
Exports (fob) Rs mNA869 0.0%   
Imports (cif) Rs m6592,209 29.8%   
Fx inflow Rs m17959 1.8%   
Fx outflow Rs m6732,612 25.8%   
Net fx Rs m-656-1,653 39.7%   
CASH FLOW
From Operations Rs m901,070 8.4%  
From Investments Rs m105-750 -14.0%  
From Financial Activity Rs m-14-150 9.4%  
Net Cashflow Rs m181171 105.6%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.8 144.8%  
Indian inst/Mut Fund % 3.8 18.2 20.9%  
FIIs % 0.1 1.0 10.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 29.1 72.9%  
Shareholders   4,783 28,591 16.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare FULFORD INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - BIOCON LTD COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS